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Summary
Background: In developing countries, a recognized etiology of paraplegia can be tuberculous
radiculomyelitis or tuberculomas, especially in patients with evidence of either active or latent
tuberculosis. These entities should also be considered in high-risk patients or in patients who have
emigrated from regions with a high prevalence of tuberculosis (TB). Both arachnoiditis and
intradural tuberculomas are uncommon forms of spinal TB.
Case reports: We report three cases of TB of the spinal cord in young males with paraplegia or
paraparesis who were hospitalized over a one-year period. The clinical presentation and clinical
course differed among the three patients: radiculomyelitis complicating tuberculous meningitis
for the first patient and spinal tuberculomas in the other two. Neuroimaging with magnetic
resonance imaging (MRI) was critical for diagnosis.
Conclusions: The therapy for spinal TB should be conservative since the neurologic deficits are
mainly secondary to the inflammatory process. Usually these lesions respond to medical therapy
alone, and with early diagnosis one can avoid unnecessary surgical intervention. In our limited
clinical experience, corticosteroids (IV, intrathecal, or both) appear to have a beneficial effect.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
Central nervous system (CNS) tuberculosis remains a serious
health problem worldwide, especially in developing coun-
tries with a high prevalence of tuberculosis (TB). Romania has* Corresponding author. Tel.: +40 723562370; fax: +40 213186090.
E-mail address: adriana_hristea@yahoo.com (A. Hristea).
201-9712/$32.00 # 2008 International Society for Infectious Diseases.
oi:10.1016/j.ijid.2007.12.004the highest prevalence of TB among all the Central European
countries, with an incidence of 126.4/100 000 population in
2005.
CNS TB has a wide and protean clinical spectrum, raising
important problems in diagnosis and institution of empiric
anti-tuberculous therapy. Indeed, a delay in the diagnosis of
this curable disease contributes to significant neurologic
sequelae. Furthermore, the mortality of patients with CNS
TB remains significant. Tuberculous disease of the CNS usuallyPublished by Elsevier Ltd. All rights reserved.
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tuberculoma. Arachnoiditis (radiculomyelitis) is reported
rarely, even in countries where CNS TB is common.1—3 Para-
plegia due to TB is often secondary to Pott’s disease, a
common cause of myelopathy in countries where TB is pre-
valent. However, TB can also cause two other forms of
myelopathy, quite rare and not part of Pott’s paraplegia:
spinal tuberculomas and granulomatous arachnoiditis result-
ing in paraplegia.2 We report three cases of tuberculosis of
the spinal cord in young males with paraplegia or paraparesis
who were hospitalized over a one-year period. Both the
clinical presentation and clinical course differed among
the three patients.
Case 1
A 20-year-old man was admitted with a 10-day history of
back pain and vomiting, followed by marked weakness of
the lower limbs and confusion during the three days prior to
admission. On admission he was febrile (38 8C) and con-
fused. Physical examination was normal except for the
neurological signs of stiff neck, bilateral positive Babinski
sign, and urinary retention. Computed tomography (CT) of
the brain showed no abnormalities of the cerebral parench-
yma except for a low degree of hydrocephalus. Cerebrosp-
inal fluid (CSF) analysis showed xanthochromic fluid that
contained 59 cells/ml, 60% lymphocytes, protein 6.5 g/l,
glucose 40 mg/dl (blood glucose 94 mg/dl), and chloride
590 mg/dl. Acid-fast stains were negative, as well as India
ink and Gram stains. Mycobacterium tuberculosis cultures
were later positive. Other investigations were normal. HIV
serology was negative and the chest X-ray was normal.
There was no evidence of active or inactive extrameningeal
TB. Anti-tuberculous therapy consisting of isoniazid (INH),
rifampin (RMP), pyrazinamide (PZA), and ethambutol (EMB)
in addition to IV dexamethasone 24 mg/day were initiated
on the second hospital day. By the fourth hospital day, the
patient had paraplegia, which was associated with asym-
metric sensory loss to pinprick at the level of D9 on the right
and D4 on the left, and loss of sphincter control. Deep
tendon reflexes were absent and bilateral Babinski sign was
found. A presumptive diagnosis of meningomyelitis was
entertained. Magnetic resonance imaging (MRI) of the spine
revealed an obliterated subarachnoidal space in the thor-
acic and lumbar segments, a subarachnoid block with
enhancement of nerve roots, and thickening of the ‘filum
terminale’. There was gadolinium (Gd) enhancement of the
lumbar meninges, suggesting extensive arachnoiditis, and a
hypersignal T2 of the spinal cord from the fourth to ninth
thoracic vertebra. IV dexamethasone was continued for two
weeks, followed by oral prednisone 1 mg/kg body weight
daily.
Twenty-four weeks from the onset, the CSF protein level
remained markedly elevated, with a peak of 59.8 g/l at 8
weeks. However, by 48 weeks the CSF protein was 0.8 g/l.
The patient was given four doses of intrathecal methylpred-
nisolone, 40 mg, at 10-day intervals starting at week eight.
Prednisone was tapered over eight weeks and the patient was
maintained on anti-tuberculous therapy for a total of 18
months. At that time, the patient had paraparesis, right
hemihypoesthesia below D9, and imperative micturition,
but could walk when supported.Case 2
A 44-year-old man, who had been treated for six months for
culture-positive TB meningitis, was admitted for paresthe-
sias in the right leg, walking difficulty, and bladder incon-
tinence. He initially improved on anti-tuberculous therapy
with INH, RMP, PZA, EMB, and systemic corticosteroids. After
two months his treatment was switched to INH and RMP three
times a week and prednisone was discontinued. Susceptibil-
ity testing of M. tuberculosis was not performed.
Physical examination on admission revealed spastic para-
paresis, bilateral extensor plantar responses, and exagger-
ated deep tendon reflexes. Asymmetric sensory loss at level
D5—7 on the right and D4—6 on the left, and urinary sphincter
dyssynergia were also noted. An MRI revealed multiple intra-
medullary lesions at D4, D5—6, D8, D10, and D11, appearing
as low intensity rings with central hyperintensity on T2-
weighted images and isointensity on the T1-weighted images,
consistent with multiple tuberculomas. In addition, the MRI
examination revealed associated osteodiscitis at L5—S1 with
no compromise of the neural canal at that level. A lumbar
puncture (LP) revealed xanthochromic fluid with 8 cells/ml
and 43.1 g/l protein. HIV serology was negative and the chest
X-ray was normal.
His regime was changed to INH, RMP, PZA, and ciproflox-
acin daily, as well as IV dexamethasone 24 mg/day for 3
weeks, followed by 16 mg daily. Methylprednisolone,
40 mg, was administered intrathecally at seven-day inter-
vals. Initially the patient slightly improved, but two days
after the second dose he complained of back pain radiating
around his waist bilaterally and inability to walk or stand with
a sensory loss below D5. The CSF protein showed a conco-
mitant increase to 43.0 g/l, compared with the protein level
of 14.8 g/l after the first intrathecal injection. Intrathecal
corticosteroids were discontinued because of possible ster-
oid-induced arachnoiditis. The other medications were con-
tinued including IV dexamethasone. A month after this
episode, he could walk when supported on one side, had
hypoesthesia below L3, diminished paresthesias, and mild
pollakiuria, and a repeat LP showed a protein level of 5.7 g/l.
Corticosteroids were tapered over 16 weeks. One year after
the onset of symptoms the CSF protein was 0.9 g/l, the
patient could walk unsupported, had a mild sensory loss,
moderate spasticity, and no sphincter disturbances.
Case 3
A 29-year-old man, who had been treated with INH, RMP, PZA,
and EMB for two months for culture-positive pulmonary TB,
was admitted for sensory loss and paresthesias followed by
progressive weakness of the lower limbs leading to walking
difficulty. On physical examination he had spastic paralysis
(could not walk and could stand only with assistance), bilat-
eral extensor plantar responses, exaggerated deep tendon
reflexes, a sensory loss below D12, and bladder incontinence.
The spinal fluid exam was normal and HIV serology was
negative. A brain CTwas normal and a chest X-ray revealed
active TB. A lumbar MRI revealed a single intramedullary
mass suggesting a tuberculoma at T8—9 with surrounding
edema. There was no evidence of vertebral TB. The M.
tuberculosis isolate was susceptible to all first-line anti-
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adequate. Anti-tuberculous therapy was continued for four
weeks and ciprofloxacin was substituted for EMB. IV dexa-
methasone, 24 mg daily, was added to the regimen. He
gradually improved over the ensuing two weeks and corti-
costeroids were therefore tapered over eight weeks. Four
weeks after admission the patient was able to walk without
assistance, and at 12 weeks he had no noticeable disability.
INH and RMP were continued for a total of 12 months. A
follow-up MRI showed complete resolution of the spinal mass,
except for a small speck of hypodensity at T8.
Discussion
Tuberculous myelopathy is a rare form of CNS TB. It has
frequently been reported in the Indian literature because
of the high prevalence of active TB in that country.2—4 The
largest series of patients was reported by Wadia and Dastur,
in which 70 patients with tuberculous granulomatous ara-
chnoiditis and myelopathy were treated between 1958 and
1967.5 Rarely, spinal arachnoiditis and tuberculomas have
also been reported from developed countries, especially in
immigrants and the elderly.2,3,6 Tuberculous meningitis
occurs in persons of all ages. In developed countries, tuber-
culous meningitis has become a disease of the elderly due to
reactivated disease, whereas subjects from areas where the
prevalence of TB is still high are much younger, and menin-
gitis is usually associated with primary infection.2,6—8 An
increase in the incidence of extrapulmonary TB, including
meningitis, is related mainly but not exclusively to the HIV
epidemic.9,10 However, our patients were seronegative for
HIV and no other reason for immunosuppression was identi-
fied.
The clinical distinction between the various forms of
spinal TB with paraplegia is often difficult in practice. A
common cause of myelopathy in developing countries where
TB is prevalent is Pott’s disease, caused by spinal cord
compression due to abscess, granulomatous tissue, or bony
displacement.9 Several authors agree that the neurologic
deficiency is secondary to medullary and radicular inflam-
mation; only exceptionally is there a compression by an
abscess or a tuberculoma.6 Two other forms of myelopathy
secondary to TB that are less common and different from
Pott’s paraplegia include tuberculomas within the spinal
cord, as well as in intra- and extradural locations,2,7—9
and encasing granulomatous arachnoiditis (radiculomyelo-
pathy) with cord compression and vasculitis of spinal cord
vessels.1—3 It has been suggested that arachnoiditis, intra-
dural spinal tuberculomas, or spinal cord complications of
tuberculous meningitis should all be grouped under the
designation ‘tuberculous radiculomyelitis’.3 In spinal cord
TB, all of these lesions (i.e., epidural, meningeal, intrame-
dullary) can cause a subarachnoid block with a markedly
elevated CSF protein concentration and pleocytosis with a
preponderance of lymphocytes.
In two of our patients, spinal TB was associated with
intracranial involvement (for example arachnoiditis compli-
cating tuberculous meningitis in patient 1 and multiple spinal
tuberculomas in patient 2). Tuberculous radiculomyelitis, a
rare complication reported in the modern literature, devel-
ops at various periods during or after tuberculous meningi-
tis.11 Occasionally patients may present with a relativelyrapid progression of paraplegia without other neurological
manifestations of TB meningitis (patient 2). Also as seen in
patient 2, spinal extension of a tuberculous basal meningitis
may appear within weeks in an inadequately or improperly
treated patient, whereas in patient 1, the radiculomyelo-
pathy was diagnosed within days after his admission for
meningoencephalitis. Spinal tuberculomas, as well as cranial
tuberculomas, as seen in our patient 3, have been described
as paradoxical growths during appropriate anti-tuberculous
treatment.12,13
The major causes of spinal arachnoiditis are spinal surgery
and diagnostic myelographic procedures. Other important
causes are spinal anesthesia, intrathecal medications, syphi-
lis, pyogenic or fungal infections, and neoplasm.2,3 The
prevalence of the non-infectious causes is more common
in the 30—50 years age group, whereas spinal TB radiculo-
myelitis occurs almost exclusively in patients under 30 years
of age.14
Radiculomyelopathy associated with TB may arise in one
of three ways. It may arise primarily in the meninges, it may
be secondary to downward extension of tuberculous basal
meningitis, or rarely secondary to osteitis. Primary tubercu-
lous radiculomyelitis starts as a hematogenous focus or foci,
either in themeninges or in the spinal cord, and subsequently
spreads to the subarachnoid space secondary to rupture of
the lesion. In contrast, in tuberculous radiculomyelitis sec-
ondary to intracranial tuberculous meningitis, the spread of
infection is apparently via the CSF pathway. The majority of
cases are secondary to intracranial TB. There is a similarity
between spinal meningomyelopathy occurring as a primary
lesion and its occurrence secondary to intracranial tubercu-
lous meningitis or to vertebral osteomyelitis.15 Tuberculous
arachnoiditis is different from other types of arachnoiditis in
that it frequently involves the spinal cord, meninges, and
nerve roots, and perhaps should be more appropriately
referred to as radiculomyelitis rather than arachnoiditis.16
During tuberculous meningitis, the frequency of spinal blocks
due to arachnoiditis with clinical manifestations of radicu-
lomyelopathy may vary from 7 to 42%.3,17
Dastur and Wadia described four major mechanisms that
lead to spinal cord involvement: (1) edema of border zones of
the cord probably secondary to venous impediment due to
pressure associated with meningitis, (2) ischemic myeloma-
lacia resulting from vasculitis or post-thrombotic occlusion of
meningeal vessels, (3) infrequent infarction of the cord from
vascular occlusion, and (4) formation of intramedullary
tuberculomas with pericentral necrosis.15 The pathological
stages in the spinal leptomeninges proceed from caseous, to
granulomatous, to chronic inflammation, and finally to fibro-
sis. Cord atrophy is seen in the later stage. In spinal ara-
chnoiditis, the underlying pathological process responsible
for cord and root damage is arachnoidal adhesions that cause
obstruction to the flow of CSF and occlusion of blood ves-
sels.17 The spinal cord and nerve roots may be surrounded by
gelatinous exudates and edema. The block of CSF in TB
radiculomyelitis has a distinct preference for the thoracic
segment.14
Clinical signs usually begin within two months and are
followed by a more rapid progressing stage that develops
over two to five days and is characterized by radicular pain,
paresthesias, weakness, and bladder dysfunction.2 When
clinical signs of meningitis with changes in mentation dom-
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was seen in our patient 1.
Tuberculomas of the spinal canal, whether they are
intradural or extradural, are uncommon as a cause of spinal
cord compression.4,7—9,18,19 Extradural lesions are usually
secondary to Pott’s disease, a common cause of paraplegia in
developing countries.2,6 Intradural spinal tuberculomasmay
be either intramedullary or mixed (intra- and extramedul-
lary) and are referred to collectively as spinal cord
tuberculomas.7 Intradural extramedullary tuberculous
granulomas are themost rare form of spinal tuberculomas.20
In India, the incidence of spinal intramedullary tuberculo-
mas is 1 in 175 cases of spinal TB and 1 in 1600 cases of CNS
TB.4 Tuberculomasmay present withmeningitis, may lead to
meningitis, or may develop during the treatment for tuber-
culous meningitis. It has been suggested that a tubercle
forms in the spinal cord, ruptures into the subarachnoid
space and causesmeningitis. During recovery, a tuberculoma
may form at the site of the original lesion with subsequent
signs of spinal cord compression, as in our patient 2. In this
patient, the presence of osteodiscitis raises the question of
concomitant osseous TB. Although tuberculous osteitis and
extradural disease may cause cord compression, spread of
infection to the intradural tissues causing meningitis is
unusual.1,3 The delayed diagnosis of osteodiscitis in patient
2 does not allow us to consider it the primary event of
tuberculous basal meningitis, subsequently complicated
with paraplegia related to multiple intramedullary tubercu-
lomas. A spinal cord tubercle can become sealed off from the
rest of the nervous system, thus explaining its presentation
in a patient without a history of tuberculous meningitis
(patient 3). The rupture of the wall of the inflammatory
tissue around the lesion related to trauma could precipitate
an acute illness.19 As noted in our patient 3, intramedullary
tuberculomas are almost always associated with active pul-
monary TB.4,18
Paradoxical deterioration during anti-tuberculosis ther-
apy remains a clinical challenge to infectious disease and
respiratory specialists.13 Although paradoxical reaction
during treatment for TB is more frequent in HIV positive
patients, it is also reported in HIV negative patients in
2—30% of cases.12,13,21 Possible explanations for these
paradoxical reactions are the recovery of the patient’s
delayed hypersensitivity response and an increase in
response to mycobacterial antigens liberated after anti-
tuberculous treatment.11 Cheng et al. found 122 such
episodes in 104 patients in the English literature. Most
of the patients (78.9%) were Asian and the CNS was the
most common site of involvement in the paradoxical
response (49% of all cases reported in the literature).
Nevertheless, the spinal cord was involved in only four
of the 60 episodes.13
Chang et al. have stated that conventional myelography
remains the primary radiographic method for suspected
tuberculous spinal radiculomyelitis, primarily in patients
with chronic adhesive changes.14 However, in patients sus-
pected of having an active inflammatory process within the
thecal sac or myelopathy, Gd—DTPA-enhanced MRI is the
optimal imaging technique. This technique can reveal
enhanced nodules suggesting tuberculomas, enhancement
of the dura-arachnoid complex around the cord, and seg-
mental enhancement of the thoracic cord suggesting eitherinfarction caused by vasculitis or tuberculous myelitis in
association with diffuse cord swelling.14,16,22 When an MRI
is performed without Gd—DTPA, it is difficult to differentiate
intramedullary tuberculomas from myelitis. In the initial
phase of tuberculoma formation, there is chronic granulo-
matous inflammation that homogenously enhances with con-
trast. When the contents of the lesion transform into caseous
material with collagen deposited along the capsule of the
granuloma, the initial lesion becomes a ring-enhancing
lesion.4
Complications such as spinal arachnoiditis that occur
during the course of the healing process of tuberculous
meningitis raise issues in themanagement of these patients.
Some authors have proposed that surgical decompression is
useful, but others have suggested that, since arachnoiditis is
diffuse, surgery may be of limited value.17 A few well-
documented case reports show that only the rare patient
withmedullary compression benefits from surgical interven-
tion.6 Steroids most likely suppress the ongoing inflamma-
tory process often seen in tuberculous meningitis despite
adequate anti-tuberculous therapy, although the exact
mechanism by which corticosteroids improve clinical out-
come remains unknown. Schoeman et al. reported that
patients treated with steroids have significantly lower CSF
protein and globulin levels after the firstmonth of treatment
and a more steady increase in glucose levels than those not
treated with steroids.23 Steroids have benefited some
patients with TB of the spinal cord.3,24 In the presence of
spinal block, it appears that steroids may arrest the increas-
ing neurological signs of cord involvement or even abort its
onset.1 Some authors consider that corticosteroids are prob-
ably beneficial and should be given for two neurological
complications associated with tuberculous meningitis: cer-
ebral edema and spinal block.11,12 In addition, intrathecal
steroids may also be useful,25,26 while other investigators
have found them of doubtful value.17 In our patient 1, a
definite therapeutic response was observed with intrathecal
administration of methylprednisolone. However, a paradox-
ical occurrence of arachnoiditis, as suggested in our patient
2, can be a serious limitation to the use of intrathecal
steroids. Hyaluronidase may be an adjuvant in the manage-
ment of spinal arachnoiditis in the subset of patients who
develop spinal arachnoiditis during therapy with systemic
steroids and anti-tuberculous agents.17
In intradural extramedullary spinal tuberculomas, pre-
vious reports have suggested that medical therapy alone will
not be adequate, and that surgical resection of the tubercu-
loma followed by anti-tuberculous therapy results in a good
outcome.19 In contrast, for intramedullary spinal tuberculo-
mas, anti-tuberculous chemotherapy alone is appropriate
management, although some authors advise surgery for all
symptomatic cases and for patients who either have profound
neurologic deficits or a progressing neurologic deficit and
poor response to appropriate anti-tuberculous agents.27,28
Management of the paradoxical deterioration includes ster-
oid therapy.11—13 The addition of corticosteroids in our
patients with single or multiple tuberculomas resulted in
an improved clinical outcome, presumably by reducing
edema. Despite the high mortality rate in the range of 30%
of exudative tuberculous meningitis with myelopathy,2 our
patients responded to medical therapy alone without the
need for surgical intervention.
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Paraplegia due to spinal cord TB is uncommon in developed
countries. However radiculomyelitis or tuberculomas should
also be considered in developing countries or in patients who
have emigrated from regions with a high prevalence of TB.
We have described three patients with tuberculous involve-
ment of the spinal cord. The three patients had rather
different features and reflect relatively uncommon forms
of spinal involvement. Our cases, describing uncommon
forms of CNS involvement due to TB, probably correspond
to some cases described in the pre-MRI older literature on TB.
Tuberculous radiculomyelitis or intramedullary tuberculomas
should be suspected whenever a patient with tuberculous
meningitis develops spinal cord symptoms. Technologies such
as MRI and culture, which are not always available to most
patients with tuberculous spinal cord involvement, are of
significant importance in characterizing the nature of the
pathological process and provide an increased opportunity to
better understand the spectrum of TB involvement in spinal
cord disease. The therapy for spinal TB should be conserva-
tive since the neurological deficits are mainly secondary to
the inflammatory process. Although the use of systemic
corticosteroids seems reasonable in the management of
spinal TB, especially in the management of paradoxical
deterioration, by our limited clinical experience their routine
use cannot be generalized.
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